跳至主要内容
临床试验/NCT00188994
NCT00188994Unknown不适用

Insulin Cardioplegia Trial for Poor Left Ventricular Function

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 800 人开始时间: 1999年8月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
800
试验地点
2
主要终点
Low Output Syndrome

研究概览

简要总结

The purpose of this investigation is to develop a means to improve the recovery of cardiac metabolism and ventricular function following coronary artery bypass surgery (CABG) in patients with poor preoperative ventricular function (e.g. ejection fraction <40%).

详细描述

Hypothesis

Insulin added to blood cardioplegia will improve the results of Coronary Artery Bypass Graft by reducing the incidence of low output syndrome (i.e., the requirement for inotropic or balloon pump assistance) in patients with a preoperative ejection fraction <40%.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has been referred for isolated coronary bypass surgery.
  • LV grade 3 or 4, LVEF <40% by angio, echo, RNA.

排除标准

  • Patient is undergoing reoperative surgery (i.e., has had any previous cardiac surgery)
  • Surgeon has planned another procedure in addition to coronary bypass surgery (e.g., valve repair, replacement, ascending aorta repair or replacement, left ventricular aneurysm resection, repair of congenital defect, carotid surgery, repair of abdominal aortic aneurysm).
  • Patient is scheduled for minimally invasive surgery.
  • More recent assessment of LV function with LV grade 1 0r 2, LVEF>40%.
  • 5 or 6 days post MI.

结局指标

主要结局

Low Output Syndrome

次要结局

  • Total Troponin I Release

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验